UniProt ID | LMNB1_HUMAN | |
---|---|---|
UniProt AC | P20700 | |
Protein Name | Lamin-B1 | |
Gene Name | LMNB1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 586 | |
Subcellular Localization |
Nucleus inner membrane Lipid-anchor Nucleoplasmic side. |
|
Protein Description | Lamins are components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane, which is thought to provide a framework for the nuclear envelope and may also interact with chromatin.. | |
Protein Sequence | MATATPVPPRMGSRAGGPTTPLSPTRLSRLQEKEELRELNDRLAVYIDKVRSLETENSALQLQVTEREEVRGRELTGLKALYETELADARRALDDTARERAKLQIELGKCKAEHDQLLLNYAKKESDLNGAQIKLREYEAALNSKDAALATALGDKKSLEGDLEDLKDQIAQLEASLAAAKKQLADETLLKVDLENRCQSLTEDLEFRKSMYEEEINETRRKHETRLVEVDSGRQIEYEYKLAQALHEMREQHDAQVRLYKEELEQTYHAKLENARLSSEMNTSTVNSAREELMESRMRIESLSSQLSNLQKESRACLERIQELEDLLAKEKDNSRRMLTDKEREMAEIRDQMQQQLNDYEQLLDVKLALDMEISAYRKLLEGEEERLKLSPSPSSRVTVSRASSSRSVRTTRGKRKRVDVEESEASSSVSISHSASATGNVCIEEIDVDGKFIRLKNTSEQDQPMGGWEMIRKIGDTSVSYKYTSRYVLKAGQTVTIWAANAGVTASPPTDLIWKNQNSWGTGEDVKVILKNSQGEEVAQRSTVFKTTIPEEEEEEEEAAGVVVEEELFHQQGTPRASNRSCAIM | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MATATPVPP ------CCCCCCCCC | 13.12 | 22223895 | |
3 | Phosphorylation | -----MATATPVPPR -----CCCCCCCCCC | 29.75 | 30108239 | |
5 | Phosphorylation | ---MATATPVPPRMG ---CCCCCCCCCCCC | 22.06 | 23401153 | |
10 | Methylation | TATPVPPRMGSRAGG CCCCCCCCCCCCCCC | 35.70 | 115481603 | |
13 | Phosphorylation | PVPPRMGSRAGGPTT CCCCCCCCCCCCCCC | 15.04 | 23403867 | |
14 | Methylation | VPPRMGSRAGGPTTP CCCCCCCCCCCCCCC | 31.36 | 24129315 | |
19 | Phosphorylation | GSRAGGPTTPLSPTR CCCCCCCCCCCCHHH | 44.30 | 29255136 | |
20 | Phosphorylation | SRAGGPTTPLSPTRL CCCCCCCCCCCHHHH | 25.93 | 29255136 | |
23 | Phosphorylation | GGPTTPLSPTRLSRL CCCCCCCCHHHHHHH | 25.98 | 19664994 | |
25 | Phosphorylation | PTTPLSPTRLSRLQE CCCCCCHHHHHHHHH | 40.65 | 29255136 | |
28 | O-linked_Glycosylation | PLSPTRLSRLQEKEE CCCHHHHHHHHHHHH | 27.88 | 28510447 | |
28 | Phosphorylation | PLSPTRLSRLQEKEE CCCHHHHHHHHHHHH | 27.88 | 26055452 | |
33 | Acetylation | RLSRLQEKEELRELN HHHHHHHHHHHHHHH | 43.45 | 23749302 | |
33 | Ubiquitination | RLSRLQEKEELRELN HHHHHHHHHHHHHHH | 43.45 | 19608861 | |
42 | Methylation | ELRELNDRLAVYIDK HHHHHHHHHHHHHHH | 24.39 | 115481619 | |
46 | Phosphorylation | LNDRLAVYIDKVRSL HHHHHHHHHHHHHCC | 9.59 | - | |
49 | Acetylation | RLAVYIDKVRSLETE HHHHHHHHHHCCCCC | 29.95 | 23749302 | |
49 | Ubiquitination | RLAVYIDKVRSLETE HHHHHHHHHHCCCCC | 29.95 | 21890473 | |
52 | Phosphorylation | VYIDKVRSLETENSA HHHHHHHCCCCCCCC | 33.28 | 28450419 | |
55 | Phosphorylation | DKVRSLETENSALQL HHHHCCCCCCCCEEE | 45.84 | 22817901 | |
58 | Phosphorylation | RSLETENSALQLQVT HCCCCCCCCEEEEEE | 24.91 | 28450419 | |
76 | Phosphorylation | EVRGRELTGLKALYE HHCCCCCHHHHHHHH | 35.40 | 24247654 | |
79 | Acetylation | GRELTGLKALYETEL CCCCHHHHHHHHHHH | 37.38 | 25953088 | |
79 | Ubiquitination | GRELTGLKALYETEL CCCCHHHHHHHHHHH | 37.38 | 21890473 | |
82 | Nitration | LTGLKALYETELADA CHHHHHHHHHHHHHH | 26.18 | - | |
82 | Phosphorylation | LTGLKALYETELADA CHHHHHHHHHHHHHH | 26.18 | 28152594 | |
84 | Phosphorylation | GLKALYETELADARR HHHHHHHHHHHHHHH | 23.81 | 24719451 | |
102 | Sumoylation | DTARERAKLQIELGK HHHHHHHHHHHHHCC | 47.33 | - | |
102 | Acetylation | DTARERAKLQIELGK HHHHHHHHHHHHHCC | 47.33 | 25953088 | |
102 | Malonylation | DTARERAKLQIELGK HHHHHHHHHHHHHCC | 47.33 | 26320211 | |
102 | Sumoylation | DTARERAKLQIELGK HHHHHHHHHHHHHCC | 47.33 | 28112733 | |
102 | Ubiquitination | DTARERAKLQIELGK HHHHHHHHHHHHHCC | 47.33 | 21906983 | |
109 | Acetylation | KLQIELGKCKAEHDQ HHHHHHCCCHHHHHH | 45.23 | 25953088 | |
109 | Ubiquitination | KLQIELGKCKAEHDQ HHHHHHCCCHHHHHH | 45.23 | - | |
111 | Acetylation | QIELGKCKAEHDQLL HHHHCCCHHHHHHHH | 61.36 | 23236377 | |
111 | Ubiquitination | QIELGKCKAEHDQLL HHHHCCCHHHHHHHH | 61.36 | - | |
121 | Nitration | HDQLLLNYAKKESDL HHHHHHHHHHHHHHC | 21.55 | - | |
123 | Acetylation | QLLLNYAKKESDLNG HHHHHHHHHHHHCCC | 46.87 | 19608861 | |
123 | Succinylation | QLLLNYAKKESDLNG HHHHHHHHHHHHCCC | 46.87 | 23954790 | |
123 | Sumoylation | QLLLNYAKKESDLNG HHHHHHHHHHHHCCC | 46.87 | 28112733 | |
123 | Ubiquitination | QLLLNYAKKESDLNG HHHHHHHHHHHHCCC | 46.87 | 21890473 | |
124 | Acetylation | LLLNYAKKESDLNGA HHHHHHHHHHHCCCC | 55.04 | 26051181 | |
124 | Ubiquitination | LLLNYAKKESDLNGA HHHHHHHHHHHCCCC | 55.04 | - | |
126 | Phosphorylation | LNYAKKESDLNGAQI HHHHHHHHHCCCCHH | 57.17 | 23401153 | |
134 | Acetylation | DLNGAQIKLREYEAA HCCCCHHHHHHHHHH | 29.43 | 25953088 | |
134 | Ubiquitination | DLNGAQIKLREYEAA HCCCCHHHHHHHHHH | 29.43 | 21890473 | |
138 | Phosphorylation | AQIKLREYEAALNSK CHHHHHHHHHHHCCH | 12.39 | 28152594 | |
144 | Phosphorylation | EYEAALNSKDAALAT HHHHHHCCHHHHHHH | 32.53 | 27251275 | |
145 | Sumoylation | YEAALNSKDAALATA HHHHHCCHHHHHHHH | 50.76 | 28112733 | |
145 | Ubiquitination | YEAALNSKDAALATA HHHHHCCHHHHHHHH | 50.76 | 21890473 | |
156 | Acetylation | LATALGDKKSLEGDL HHHHHCCHHHHCCCH | 42.33 | 25953088 | |
156 | Ubiquitination | LATALGDKKSLEGDL HHHHHCCHHHHCCCH | 42.33 | - | |
157 | Acetylation | ATALGDKKSLEGDLE HHHHCCHHHHCCCHH | 66.08 | 19608861 | |
157 | Sumoylation | ATALGDKKSLEGDLE HHHHCCHHHHCCCHH | 66.08 | 28112733 | |
157 | Ubiquitination | ATALGDKKSLEGDLE HHHHCCHHHHCCCHH | 66.08 | 21890473 | |
158 | Phosphorylation | TALGDKKSLEGDLED HHHCCHHHHCCCHHH | 37.08 | 28355574 | |
167 | Ubiquitination | EGDLEDLKDQIAQLE CCCHHHHHHHHHHHH | 60.97 | - | |
176 | Phosphorylation | QIAQLEASLAAAKKQ HHHHHHHHHHHHHHH | 14.79 | 28555341 | |
181 | Acetylation | EASLAAAKKQLADET HHHHHHHHHHHCCCH | 36.00 | 19608861 | |
181 | Succinylation | EASLAAAKKQLADET HHHHHHHHHHHCCCH | 36.00 | 23954790 | |
181 | Sumoylation | EASLAAAKKQLADET HHHHHHHHHHHCCCH | 36.00 | 28112733 | |
181 | Ubiquitination | EASLAAAKKQLADET HHHHHHHHHHHCCCH | 36.00 | 19608861 | |
182 | Acetylation | ASLAAAKKQLADETL HHHHHHHHHHCCCHH | 45.90 | 26051181 | |
182 | Ubiquitination | ASLAAAKKQLADETL HHHHHHHHHHCCCHH | 45.90 | 21890473 | |
188 | Phosphorylation | KKQLADETLLKVDLE HHHHCCCHHHHCCHH | 37.63 | 29496963 | |
191 | Acetylation | LADETLLKVDLENRC HCCCHHHHCCHHHHH | 36.49 | 26051181 | |
197 | Methylation | LKVDLENRCQSLTED HHCCHHHHHHHHHHC | 15.52 | 115481651 | |
198 | Glutathionylation | KVDLENRCQSLTEDL HCCHHHHHHHHHHCH | 4.93 | 22555962 | |
200 | Phosphorylation | DLENRCQSLTEDLEF CHHHHHHHHHHCHHH | 40.67 | 23401153 | |
202 | Phosphorylation | ENRCQSLTEDLEFRK HHHHHHHHHCHHHHH | 32.47 | 23403867 | |
209 | Acetylation | TEDLEFRKSMYEEEI HHCHHHHHHHHHHHH | 44.91 | 25825284 | |
209 | Ubiquitination | TEDLEFRKSMYEEEI HHCHHHHHHHHHHHH | 44.91 | 21906983 | |
210 | Phosphorylation | EDLEFRKSMYEEEIN HCHHHHHHHHHHHHH | 23.49 | 23401153 | |
211 | Sulfoxidation | DLEFRKSMYEEEINE CHHHHHHHHHHHHHH | 5.68 | 21406390 | |
212 | Phosphorylation | LEFRKSMYEEEINET HHHHHHHHHHHHHHH | 27.55 | 28796482 | |
219 | Phosphorylation | YEEEINETRRKHETR HHHHHHHHHHHHCEE | 31.14 | 27251275 | |
222 | Ubiquitination | EINETRRKHETRLVE HHHHHHHHHCEEEEE | 42.37 | - | |
232 | Phosphorylation | TRLVEVDSGRQIEYE EEEEEECCCCCEEHH | 40.84 | 23401153 | |
238 | Phosphorylation | DSGRQIEYEYKLAQA CCCCCEEHHHHHHHH | 26.62 | - | |
241 | Sumoylation | RQIEYEYKLAQALHE CCEEHHHHHHHHHHH | 25.96 | - | |
241 | Acetylation | RQIEYEYKLAQALHE CCEEHHHHHHHHHHH | 25.96 | 26822725 | |
241 | Sumoylation | RQIEYEYKLAQALHE CCEEHHHHHHHHHHH | 25.96 | 28112733 | |
241 | Ubiquitination | RQIEYEYKLAQALHE CCEEHHHHHHHHHHH | 25.96 | 21890473 | |
249 | Sulfoxidation | LAQALHEMREQHDAQ HHHHHHHHHHHHHHH | 3.88 | 21406390 | |
250 | Methylation | AQALHEMREQHDAQV HHHHHHHHHHHHHHH | 37.12 | 115481627 | |
260 | Phosphorylation | HDAQVRLYKEELEQT HHHHHHHHHHHHHHH | 13.04 | 27642862 | |
261 | Sumoylation | DAQVRLYKEELEQTY HHHHHHHHHHHHHHH | 49.67 | - | |
261 | Acetylation | DAQVRLYKEELEQTY HHHHHHHHHHHHHHH | 49.67 | 25953088 | |
261 | Sumoylation | DAQVRLYKEELEQTY HHHHHHHHHHHHHHH | 49.67 | 28112733 | |
261 | Ubiquitination | DAQVRLYKEELEQTY HHHHHHHHHHHHHHH | 49.67 | 21890473 | |
267 | Phosphorylation | YKEELEQTYHAKLEN HHHHHHHHHHHHHHH | 14.11 | 28152594 | |
268 | Phosphorylation | KEELEQTYHAKLENA HHHHHHHHHHHHHHH | 10.24 | 28152594 | |
271 | Acetylation | LEQTYHAKLENARLS HHHHHHHHHHHHHHC | 42.92 | 19608861 | |
271 | Sumoylation | LEQTYHAKLENARLS HHHHHHHHHHHHHHC | 42.92 | 28112733 | |
271 | Ubiquitination | LEQTYHAKLENARLS HHHHHHHHHHHHHHC | 42.92 | 21890473 | |
278 | Phosphorylation | KLENARLSSEMNTST HHHHHHHCHHCCHHH | 20.78 | 30266825 | |
279 | Phosphorylation | LENARLSSEMNTSTV HHHHHHCHHCCHHHH | 45.52 | 30266825 | |
281 | Sulfoxidation | NARLSSEMNTSTVNS HHHHCHHCCHHHHHH | 7.77 | 21406390 | |
283 | Phosphorylation | RLSSEMNTSTVNSAR HHCHHCCHHHHHHHH | 25.19 | 30266825 | |
284 | Phosphorylation | LSSEMNTSTVNSARE HCHHCCHHHHHHHHH | 25.92 | 23401153 | |
285 | Phosphorylation | SSEMNTSTVNSAREE CHHCCHHHHHHHHHH | 22.97 | 30266825 | |
288 | Phosphorylation | MNTSTVNSAREELME CCHHHHHHHHHHHHH | 25.11 | 30266825 | |
297 | Methylation | REELMESRMRIESLS HHHHHHHHHHHHHHH | 12.70 | 115481611 | |
299 | Methylation | ELMESRMRIESLSSQ HHHHHHHHHHHHHHH | 28.54 | 115481643 | |
302 | Phosphorylation | ESRMRIESLSSQLSN HHHHHHHHHHHHHHH | 31.05 | 30266825 | |
304 | Phosphorylation | RMRIESLSSQLSNLQ HHHHHHHHHHHHHHH | 25.89 | 30266825 | |
305 | Phosphorylation | MRIESLSSQLSNLQK HHHHHHHHHHHHHHH | 40.20 | 30266825 | |
308 | Phosphorylation | ESLSSQLSNLQKESR HHHHHHHHHHHHHHH | 28.05 | 26074081 | |
312 | Acetylation | SQLSNLQKESRACLE HHHHHHHHHHHHHHH | 61.90 | 25953088 | |
312 | Malonylation | SQLSNLQKESRACLE HHHHHHHHHHHHHHH | 61.90 | 26320211 | |
312 | Sumoylation | SQLSNLQKESRACLE HHHHHHHHHHHHHHH | 61.90 | 28112733 | |
312 | Ubiquitination | SQLSNLQKESRACLE HHHHHHHHHHHHHHH | 61.90 | 21890473 | |
330 | Acetylation | ELEDLLAKEKDNSRR HHHHHHHHCCCCHHC | 66.33 | 25953088 | |
330 | Sumoylation | ELEDLLAKEKDNSRR HHHHHHHHCCCCHHC | 66.33 | 28112733 | |
330 | Ubiquitination | ELEDLLAKEKDNSRR HHHHHHHHCCCCHHC | 66.33 | 21906983 | |
340 | Phosphorylation | DNSRRMLTDKEREMA CCHHCCCCHHHHHHH | 35.36 | 21406692 | |
342 | Acetylation | SRRMLTDKEREMAEI HHCCCCHHHHHHHHH | 54.13 | 25953088 | |
342 | Ubiquitination | SRRMLTDKEREMAEI HHCCCCHHHHHHHHH | 54.13 | - | |
353 | Sulfoxidation | MAEIRDQMQQQLNDY HHHHHHHHHHHHCCH | 4.56 | 28465586 | |
360 | Phosphorylation | MQQQLNDYEQLLDVK HHHHHCCHHHHHHHH | 12.42 | 28796482 | |
375 | Phosphorylation | LALDMEISAYRKLLE HHHHCHHHHHHHHHC | 13.12 | 30266825 | |
377 | Phosphorylation | LDMEISAYRKLLEGE HHCHHHHHHHHHCCH | 11.07 | 23403867 | |
379 | Sumoylation | MEISAYRKLLEGEEE CHHHHHHHHHCCHHH | 44.76 | - | |
379 | Acetylation | MEISAYRKLLEGEEE CHHHHHHHHHCCHHH | 44.76 | 22631273 | |
379 | Sumoylation | MEISAYRKLLEGEEE CHHHHHHHHHCCHHH | 44.76 | - | |
379 | Ubiquitination | MEISAYRKLLEGEEE CHHHHHHHHHCCHHH | 44.76 | 21906983 | |
387 | Methylation | LLEGEEERLKLSPSP HHCCHHHHHCCCCCC | 40.16 | - | |
389 | Sumoylation | EGEEERLKLSPSPSS CCHHHHHCCCCCCCC | 53.81 | - | |
389 | Acetylation | EGEEERLKLSPSPSS CCHHHHHCCCCCCCC | 53.81 | 25953088 | |
389 | Sumoylation | EGEEERLKLSPSPSS CCHHHHHCCCCCCCC | 53.81 | - | |
389 | Ubiquitination | EGEEERLKLSPSPSS CCHHHHHCCCCCCCC | 53.81 | 21890473 | |
391 | Phosphorylation | EEERLKLSPSPSSRV HHHHHCCCCCCCCCE | 23.03 | 29255136 | |
393 | Phosphorylation | ERLKLSPSPSSRVTV HHHCCCCCCCCCEEE | 33.76 | 29255136 | |
395 | Phosphorylation | LKLSPSPSSRVTVSR HCCCCCCCCCEEEEC | 34.80 | 29255136 | |
396 | Phosphorylation | KLSPSPSSRVTVSRA CCCCCCCCCEEEECC | 33.87 | 29255136 | |
399 | Phosphorylation | PSPSSRVTVSRASSS CCCCCCEEEECCCCC | 16.20 | 30266825 | |
401 | O-linked_Glycosylation | PSSRVTVSRASSSRS CCCCEEEECCCCCCC | 16.86 | 28510447 | |
401 | Phosphorylation | PSSRVTVSRASSSRS CCCCEEEECCCCCCC | 16.86 | 23401153 | |
404 | Phosphorylation | RVTVSRASSSRSVRT CEEEECCCCCCCCCC | 27.95 | 23927012 | |
405 | Phosphorylation | VTVSRASSSRSVRTT EEEECCCCCCCCCCC | 28.87 | 30266825 | |
406 | Phosphorylation | TVSRASSSRSVRTTR EEECCCCCCCCCCCC | 26.53 | 30266825 | |
408 | Phosphorylation | SRASSSRSVRTTRGK ECCCCCCCCCCCCCC | 20.21 | 27273156 | |
411 | Phosphorylation | SSSRSVRTTRGKRKR CCCCCCCCCCCCCEE | 20.77 | 26074081 | |
412 | Phosphorylation | SSRSVRTTRGKRKRV CCCCCCCCCCCCEEC | 27.19 | 26074081 | |
413 | Methylation | SRSVRTTRGKRKRVD CCCCCCCCCCCEECC | 48.28 | - | |
457 | Ubiquitination | DGKFIRLKNTSEQDQ CCCEEEEECCCCCCC | 48.62 | - | |
460 | Phosphorylation | FIRLKNTSEQDQPMG EEEEECCCCCCCCCC | 42.53 | - | |
474 | Acetylation | GGWEMIRKIGDTSVS CCHHHHHHHCCCEEE | 39.87 | 26051181 | |
474 | Malonylation | GGWEMIRKIGDTSVS CCHHHHHHHCCCEEE | 39.87 | 26320211 | |
474 | Ubiquitination | GGWEMIRKIGDTSVS CCHHHHHHHCCCEEE | 39.87 | - | |
478 | Phosphorylation | MIRKIGDTSVSYKYT HHHHHCCCEEEEEEE | 26.30 | 23186163 | |
479 | Phosphorylation | IRKIGDTSVSYKYTS HHHHCCCEEEEEEEE | 17.51 | 21815630 | |
481 | Phosphorylation | KIGDTSVSYKYTSRY HHCCCEEEEEEEEEE | 18.70 | 30108239 | |
482 | Nitration | IGDTSVSYKYTSRYV HCCCEEEEEEEEEEE | 13.08 | - | |
483 | Acetylation | GDTSVSYKYTSRYVL CCCEEEEEEEEEEEE | 34.25 | 19608861 | |
483 | Ubiquitination | GDTSVSYKYTSRYVL CCCEEEEEEEEEEEE | 34.25 | 21890473 | |
484 | Phosphorylation | DTSVSYKYTSRYVLK CCEEEEEEEEEEEEE | 11.17 | 23882029 | |
506 | Phosphorylation | WAANAGVTASPPTDL EEECCCCCCCCCCEE | 22.09 | 28348404 | |
508 | Phosphorylation | ANAGVTASPPTDLIW ECCCCCCCCCCEEEE | 23.26 | 28348404 | |
528 | Acetylation | WGTGEDVKVILKNSQ CCCCCCEEEEEECCC | 35.56 | 25953088 | |
528 | Ubiquitination | WGTGEDVKVILKNSQ CCCCCCEEEEEECCC | 35.56 | 21890473 | |
532 | Acetylation | EDVKVILKNSQGEEV CCEEEEEECCCCCCH | 43.35 | 25825284 | |
532 | Malonylation | EDVKVILKNSQGEEV CCEEEEEECCCCCCH | 43.35 | 26320211 | |
532 | Sumoylation | EDVKVILKNSQGEEV CCEEEEEECCCCCCH | 43.35 | 28112733 | |
532 | Ubiquitination | EDVKVILKNSQGEEV CCEEEEEECCCCCCH | 43.35 | 21890473 | |
534 | Phosphorylation | VKVILKNSQGEEVAQ EEEEEECCCCCCHHH | 37.67 | 25159151 | |
543 | Phosphorylation | GEEVAQRSTVFKTTI CCCHHHHCEEEEECC | 19.49 | 28450419 | |
544 | Phosphorylation | EEVAQRSTVFKTTIP CCHHHHCEEEEECCC | 31.95 | 28450419 | |
547 | Acetylation | AQRSTVFKTTIPEEE HHHCEEEEECCCHHH | 40.18 | 26051181 | |
547 | Sumoylation | AQRSTVFKTTIPEEE HHHCEEEEECCCHHH | 40.18 | 28112733 | |
547 | Ubiquitination | AQRSTVFKTTIPEEE HHHCEEEEECCCHHH | 40.18 | 2190698 | |
548 | Phosphorylation | QRSTVFKTTIPEEEE HHCEEEEECCCHHHH | 20.63 | 25849741 | |
549 | Phosphorylation | RSTVFKTTIPEEEEE HCEEEEECCCHHHHH | 34.82 | 25849741 | |
575 | Phosphorylation | ELFHQQGTPRASNRS HHHHCCCCCCCCCCC | 12.79 | 25159151 | |
579 | Phosphorylation | QQGTPRASNRSCAIM CCCCCCCCCCCCCCC | 33.77 | 19007248 | |
583 | Farnesylation | PRASNRSCAIM---- CCCCCCCCCCC---- | 2.41 | 2684976 | |
583 | Farnesylation | PRASNRSCAIM---- CCCCCCCCCCC---- | 2.41 | 2684976 | |
583 | Methylation | PRASNRSCAIM---- CCCCCCCCCCC---- | 2.41 | 10679189 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
23 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
23 | S | Phosphorylation | Kinase | CDK-FAMILY | - | GPS |
23 | S | Phosphorylation | Kinase | CDK_GROUP | - | PhosphoELM |
393 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
393 | S | Phosphorylation | Kinase | CDK-FAMILY | - | GPS |
393 | S | Phosphorylation | Kinase | CDK_GROUP | - | PhosphoELM |
395 | S | Phosphorylation | Kinase | KPCB | P05771 | PhosphoELM |
395 | S | Phosphorylation | Kinase | PRKCB | P05771-2 | GPS |
396 | S | Phosphorylation | Kinase | PKC-FAMILY | - | GPS |
396 | S | Phosphorylation | Kinase | PKC_GROUP | - | PhosphoELM |
405 | S | Phosphorylation | Kinase | KPCB | P05771 | PhosphoELM |
405 | S | Phosphorylation | Kinase | PRKCB | P05771-2 | GPS |
406 | S | Phosphorylation | Kinase | PKC-FAMILY | - | GPS |
406 | S | Phosphorylation | Kinase | PKC_GROUP | - | PhosphoELM |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LMNB1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LMNB1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
KPCA_HUMAN | PRKCA | physical | 12135703 | |
NDEL1_HUMAN | NDEL1 | physical | 19198602 | |
AIRE_HUMAN | AIRE | physical | 20085707 | |
PO2F1_HUMAN | POU2F1 | physical | 21897860 | |
PCGF2_HUMAN | PCGF2 | physical | 19727227 | |
LMNA_HUMAN | LMNA | physical | 19727227 | |
EGF_HUMAN | EGF | physical | 19727227 | |
NICA_HUMAN | NCSTN | physical | 22939629 | |
MAGT1_HUMAN | MAGT1 | physical | 22939629 | |
URB2_HUMAN | URB2 | physical | 15265697 | |
AACT_HUMAN | SERPINA3 | physical | 21988832 | |
MBIP1_HUMAN | MBIP | physical | 21988832 | |
ZZEF1_HUMAN | ZZEF1 | physical | 22863883 | |
IMA3_HUMAN | KPNA4 | physical | 26344197 | |
RFA1_HUMAN | RPA1 | physical | 26344197 | |
RFA3_HUMAN | RPA3 | physical | 26344197 | |
SF3B3_HUMAN | SF3B3 | physical | 26344197 | |
SRSF6_HUMAN | SRSF6 | physical | 26344197 | |
PIAS2_HUMAN | PIAS2 | physical | 21516116 | |
MLP3B_HUMAN | MAP1LC3B | physical | 26524528 | |
LMNA_HUMAN | LMNA | physical | 26524528 | |
LMNB2_HUMAN | LMNB2 | physical | 26524528 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
OMIM Disease | ||||||
169500 | Leukodystrophy, demyelinating, autosomal dominant, adult-onset (ADLD) | |||||
Kegg Drug | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-5; THR-20 AND SER-23, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-157; LYS-271 AND LYS-483,AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-20; SER-23; SER-375 ANDTHR-575, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-5; THR-20 AND SER-23, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-20; SER-23 AND THR-575,AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-20 AND SER-23, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23, AND MASSSPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23; SER-278; SER-279;SER-284; SER-391 AND SER-579, AND MASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23, AND MASSSPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-20; SER-23 AND SER-391,AND MASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-20 AND SER-23, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19; SER-23; SER-28;SER-200; SER-404 AND THR-575, AND MASS SPECTROMETRY. | |
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."; Kim J.-E., Tannenbaum S.R., White F.M.; J. Proteome Res. 4:1339-1346(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-391 AND SER-393, ANDMASS SPECTROMETRY. | |
Prenylation | |
Reference | PubMed |
"Human lamin B contains a farnesylated cysteine residue."; Farnsworth C.C., Wolda S.L., Gelb M.H., Glomset J.A.; J. Biol. Chem. 264:20422-20429(1989). Cited for: ISOPRENYLATION AT CYS-583. |